ReP USP - Resultado da busca

Filtros : "Financiamento PNPD/CAPES" "Indexado no BIOBASE" Limpar

Filtros

Indexado em
- indexado no biobase (2)
- indexado no current contents (2)
- indexado no embase (2)
- indexado no global health (2)
- indexado no medline (2)

Artigo de periodico
Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity (2020)
Silva, Juliana Almeida da ; Almada, Rafael Carvalho ; Paiva, Yara Bezerra de ; Coimbra, Norberto Cysne
Source: Journal of Neural Transmission. Unidade: FMRP
Subjects: MEDO, PÂNICO, NEURÔNIOS, CANABINOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Juliana Almeida da et al. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity. Journal of Neural Transmission, v. 127, n. 8, p. 1199-1208, 2020Tradução . . Disponível em: https://doi.org/10.1007/s00702-020-02217-8. Acesso em: 09 nov. 2025.
APA
Silva, J. A. da, Almada, R. C., Paiva, Y. B. de, & Coimbra, N. C. (2020). Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity. Journal of Neural Transmission, 127( 8), 1199-1208. doi:10.1007/s00702-020-02217-8
NLM
Silva JA da, Almada RC, Paiva YB de, Coimbra NC. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity [Internet]. Journal of Neural Transmission. 2020 ; 127( 8): 1199-1208.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1007/s00702-020-02217-8
Vancouver
Silva JA da, Almada RC, Paiva YB de, Coimbra NC. Endocannabinoid neuromodulation in the neostriatum decreases the GABAergic striato-nigral disinhibitory function and increases the nigro-collicular inhibitory pathway activity [Internet]. Journal of Neural Transmission. 2020 ; 127( 8): 1199-1208.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1007/s00702-020-02217-8
Artigo de periodico
Anatomical and clinical implications of vagal modulation of the spleen (2020)
Bassi, Gabriel S.; Kanashiro, Alexandre; Coimbra, Norberto Cysne ; Terrando, Niccolò; Maixner, William; Ulloa, Luis
Source: Neuroscience & Biobehavioral Reviews. Unidade: FMRP
Subjects: NERVO VAGO, BAÇO, ACETILCOLINA, NOREPINEFRINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASSI, Gabriel S. et al. Anatomical and clinical implications of vagal modulation of the spleen. Neuroscience & Biobehavioral Reviews, v. 112, p. 363-373, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.neubiorev.2020.02.011. Acesso em: 09 nov. 2025.
APA
Bassi, G. S., Kanashiro, A., Coimbra, N. C., Terrando, N., Maixner, W., & Ulloa, L. (2020). Anatomical and clinical implications of vagal modulation of the spleen. Neuroscience & Biobehavioral Reviews, 112, 363-373. doi:10.1016/j.neubiorev.2020.02.011
NLM
Bassi GS, Kanashiro A, Coimbra NC, Terrando N, Maixner W, Ulloa L. Anatomical and clinical implications of vagal modulation of the spleen [Internet]. Neuroscience & Biobehavioral Reviews. 2020 ; 112 363-373.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1016/j.neubiorev.2020.02.011
Vancouver
Bassi GS, Kanashiro A, Coimbra NC, Terrando N, Maixner W, Ulloa L. Anatomical and clinical implications of vagal modulation of the spleen [Internet]. Neuroscience & Biobehavioral Reviews. 2020 ; 112 363-373.[citado 2025 nov. 09 ] Available from: https://doi.org/10.1016/j.neubiorev.2020.02.011

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2025